OncLive December Recap: FDA Approval Highlights
In case you missed it, below are some of the drugs that were approved by the FDA in the month of December.
Source: onclive.com
📰 Bone Marrow Transplantation Program News
Bone Marrow Transplantation Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bone Marrow Transplantation Program. Real-time updates on events, politics, business and more.
Final APPLY-PNH Data Support Use of Iptacopan in PNH With Persistent Anemia
Oral iptacopan (Fabhalta) monotherapy induced durable responses and hemolysis control in patients with paroxysmal nocturnal hemoglobinuria and persistent anemia who had previously received anti-C5 treatment.
Antoniom Risitano Bone Marrow Transplantation Program University Of Naples Federico Naples Federico Oral Iptacopan Monotherapy Patients With Paroxysmal Nocturnal Hemoglobinuria And Persistent Anemia
Source: onclive.com
Burjeel Medical City and UK-based Digipharm Collaborate to Improve Access to Value-based Healthcare
To provide the best advanced health technologies and create an enhanced end-to-end patient experience, Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, and Digipharm, a UK-based innovative healthcare solutions provider, have joined hands to design and validate a new model for patient care in the UAE.
United Kingdom Ahmed Abdulla John Sunil Burjeel Holdings Bone Marrow Transplantation Program International Consortium For Health Outcomes Measurements
Source: eyeofarabia.com
K36 Therapeutics Announces FDA Clearance of Investigational New Drug Application and Formation of Clinical Advisory Board for Lead Program KTX-1001
/PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately held biotechnology company developing novel targeted therapies for the unmet medical needs of...
Source: prnewswire.com
Cancer Care at Burjeel Medical City: Changing lives and giving hope
Burjeel Medical City provides oncology care in all adult and pediatric treatments
Source: gulfnews.com
Mena Stem Cell Forum to focus on $467bn global industry
The Middle Eastern countries are sharpening their focus on the $467 billion global stem cell market which will come under scrutiny at the first Mena Stem Cell Forum taking place from March 18 to 19, 2022.
Source: tradearabia.com
Mena Stem Cell Forum to focus on $467bn global industry
The Middle Eastern countries are sharpening their focus on the $467 billion global stem cell market which will come under scrutiny at the first Mena Stem Cell Forum taking place from March 18 to 19, 2022.
Source: tradearabia.com
Overall survival rate has nearly doubled for Ph+ ALL patients after hematopoietic stem cell transplant
For patients with acute lymphoblastic leukemia (ALL) carrying the Philadelphia chromosome and whose disease relapsed after allogeneic hematopoietic stem cell transplantation (HCT), the two-year overall survival rate has nearly doubled from the period between 2000 and 2004 to the period between 2015 and 2019.
United States Ali Bazarbachi Emily Henderson American Association For Cancer Research American University Of Beirut Bone Marrow Transplantation Program
Source: news-medical.net
Survival rate of adult patients with relapsed acute lymphoblastic leukemia after hematopoietic cell transplantation has steadily
Bottom Line: For patients with acute lymphoblastic leukemia (ALL) carrying the Philadelphia chromosome and whose disease relapsed after allogeneic
United States Ali Bazarbachi American Association For Cancer Research Leukemia Working Party American University Of Beirut Bone Marrow Transplantation Program
Source: miragenews.com
New Data from CARTITUDE-1 Study Show Continued Deep and Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) in Treatment of Heavily Pretreated Patients with Multiple Myeloma
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today longer-term results from the Phase 1b/2 CARTITUDE-1 study evaluating...
Source: prnewswire.com